Skip to main content
Maria Papaleontiou, MD, Endocrinology, Ann Arbor, MI, University of Michigan Medical Center

MariaPapaleontiouMD

Endocrinology Ann Arbor, MI

Thyroid

Physician

Dr. Papaleontiou is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Papaleontiou's full profile

Already have an account?

Clinical Expertise

  • Thyroid disorders, Osteoporosis, Thyroid diseases

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemFellowship, Endocrinology, Diabetes, and Metabolism, 2011 - 2013
  • Saint Peter's University Hospital/Rutgers Robert Wood Johnson Medical School
    Saint Peter's University Hospital/Rutgers Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2008 - 2011
  • Charles University in Prague Faculty of Medicine
    Charles University in Prague Faculty of MedicineClass of 2004

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2011 - 2026
  • NJ State Medical License
    NJ State Medical License 2009 - 2013
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Publications & Presentations

PubMed

Lectures

  • Year in Thyroid Healthcare Delivery 
    ENDO 2019 - New Orleans, LA - 3/24/2019

Authored Content

  • Empowering Future Leaders in Thyroidology: Reflections from the 89th ATANovember 2019

Press Mentions

  • Thyroid Hormone Treatment Intensity Linked to Increased Risk of Cardiovascular Mortality
    Thyroid Hormone Treatment Intensity Linked to Increased Risk of Cardiovascular MortalityJune 17th, 2022
  • Exogenous Hyper-, Hypothyroidism Increase Risk for CV Mortality
    Exogenous Hyper-, Hypothyroidism Increase Risk for CV MortalityJune 10th, 2022
  • Keeping Thyroid Hormone Treatment on Target Is Key for the Heart
    Keeping Thyroid Hormone Treatment on Target Is Key for the HeartMay 18th, 2022
  • Join now to see all

Grant Support

  • The Effect of Inappropriate Use of Thyroid Hormone Replacement in Older MenNational Institute on AgingPresent

Committees

  • Vice-Chair, American Association of Clinical Endocrinology Thyroid Disease Network 2022 - Present
  • Chair, North American Society of Interventional Thyroidology Ethics Committee 2022 - Present
  • Chair, American Thyroid Association Annual Program Committee 2021 - 2022
  • Member, American Association of Clinical Endocrinology Professional Standards Committee 2021 - 2022
  • Member, American Thyroid Association Annual Program Committee 2020 - 2021
  • Co-Chair, AACE Abstract Subcommittee 2019 - 2022
  • Member, American Thyroid Association Research Committee 2018 - 2019
  • Vice-Chair, American Association of Clinical Endocrinologists Public Impact Committee 2018 - 2019
  • Member, American Thyroid Association Patient Affairs and Education Committee 2013 - 2018

Professional Memberships

Hospital Affiliations